pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 6·1 min read
save

Ebola therapy development accelerates as multiple candidates enter early trials

Jul 6, 2026·read at STAT ↗Neutral

A new wave of research teams are racing to develop a therapy for Ebola, according to the latest Morning Rounds newsletter.

The article notes that several candidates are now moving into early‑stage testing, reflecting renewed urgency after recent outbreaks.

In a separate note, Republican lawmakers are urging greater diversity in clinical trials after previous policy changes reduced DEI references.

The newsletter also touches on other health topics, including marathon fatigue and mental health outlooks for 2026, highlighting its broad coverage.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “The race for an Ebola therapy begins”

read at STAT ↗
1,205 words · retrieved Jul 6
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
GILEADGILEAD SCIENCES INCRISING
drugs
VEKLURY3remdesivir3MBP-1342NVCov-2R2
topics
Psychiatry & CNS9Monoclonal Antibody2Vaccine2OncologyVaccines

related stories

  • May 29STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and moreSTAT
  • May 29Which vaccines will curb the Ebola outbreak? WHO debatesSTAT
  • 5h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • 3d agoA winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT
  • Aug 10Opinion: We prepared for Ebola — but not this EbolaSTAT